Patent ID: 7572576

Claim:
A method for assessing the genetic risk for hypertension in a human male subject, the method comprising the following steps (i) to (iii): (i) analyzing the following polymorphisms (1) to (3) in a nucleic acid sample from the human male subject: (1) a polymorphism at the base number position 1648 of the glycoprotein Ia (Gpla) gene, wherein the polymorphism is A1648G; (2) a polymorphism at the base number position 190 of the chemokine receptor 2 (CCR2) gene, wherein the polymorphism is G190A; and (3) a polymorphism at the base number position 1100 of the apolipoprotein C-III (apo CIII) gene, wherein the polymorphism is C1100T; (ii) determining, based on the information about polymorphisms which was obtained in the step (i), the genotype of the nucleic acid sample from the human male subject; and (iii) assessing, based on the genotype determined, a genetic risk for hypertension in the human male subject, wherein a genotype including A at position 1648 of the Gpla gene, A at position 190 of the CCR2 gene, and C at position 1100 of the apo CIII gene indicates a genetic risk for hypertension in the human male subject.